Background: Patient activation comprises the knowledge, skills, and confidence for self-care and may lead to better health outcomes. Objectives: We examined the relationship between patient activation and changes in health-related quality of life (HRQOL) after hospitalization for an acute coronary syndrome (ACS). Methods: We studied patients from 6 medical centers in central Massachusetts and Georgia who had been hospitalized for an ACS between 2011 and 2013. At 1 month after hospital discharge, the patients completed the 6-item Patient Activation Measure and were categorized into 4 levels of activation. Multinomial logistic regression analyses compared activation level with clinically meaningful changes (Q3.0 points, generic; Q10.0 points, disease-specific) in generic physical (SF-36v2 Physical Component Summary [PCS]), generic mental (SF-36v2 Mental Component Summary [MCS]), and disease-specific (Seattle Angina Questionnaire [SAQ]) HRQOL from 1 to 3 and 1 to 6 months after hospitalization, adjusting for potential sociodemographic and clinical confounders. Results: The patients (N = 1042) were, on average, 62 years old, 34% female, and 87% non-Hispanic white. A total of 10% were in the lowest level of activation. The patients with the lowest activation had 1.95 times (95% confidence interval, 1.05Y3.62) and 2.18 times (95% confidence interval, 1.17Y4.05) the odds of experiencing clinically significant declines in MCS and SAQ HRQOL, respectively, between 1 and 6 months than the most activated patients. The patient activation level was not associated with meaningful changes in PCS scores. Conclusions: Hospital survivors of an ACS with lower activation may be more likely to experience declines in mental and disease-specific HRQOL than more-activated patients, identifying a group at risk of poor outcomes.
Self-care can require substantial knowledge, skills, and confidence, terms collectively described as ''patient activation.'' 6 Because more-activated patients are more likely to engage in self-care activities, 7Y9 patient activation may be required to maintain, if not improve, HRQOL after an ACS.
The role of patient activation in prognosis among survivors of an ACS remains unclear because previous studies have pooled patients with and without heart disease. 6, 10, 11 Although cross sectional studies in general populations suggest a positive association between patient activation and HRQOL, 11, 12 we are unaware of previous studies on how patient activation may predict subsequent changes in HRQOL. Because clinical interventions may improve patient activation, 13 knowledge about the relationship between patient activation and changes in HRQOL may be valuable for treating patients with an ACS. We hypothesized that patients with low activation were more likely to experience declines in general and disease-specific HRQOL than moreactivated patients in the sixth month after hospitalization for an ACS.
Methods

Study Setting and Sample
We used data from the Transitions, Risks, and Actions in Coronary Events: Center for Outcomes Research and Education. 14, 15 Adults hospitalized with an ACS were recruited at 3 hospitals in Worcester, Massachusetts, 1 in Macon, Georgia, and 2 in Atlanta, Georgia, from 2011 to 2013. These sites were selected to facilitate the recruitment of a cohort with racial and socioeconomic diversity. 15 Eligibility criteria included a confirmed diagnosis of an ACS, 16 ,17 aged 21 years or older, and being discharged alive. Exclusion criteria included having an ACS secondary to another acute medical event, delirium, pregnancy, and receiving hospice or palliative care. The data were collected by chart abstraction, an in-person interview during the index hospitalization or by telephone within 72 hours of discharge, and telephone interviews at 1, 3, 6, and 12 months after hospital discharge. Institutional review boards at each study site approved this study. The present study sample consisted of patients with complete data on patient activation at 1 month; HRQOL at 1, 3, and 6 months; and sociodemographic and clinical covariates.
Patient Activation
We examined patient activation at 1 month after hospital discharge because this measurement reflects changes in activation resulting from discharge education and outpatient follow-up. 9, 18 Patient activation was measured using the 6-item Patient Activation Measure (PAM) (PAM-6), a shortened version of the validated 13-item PAM. 6, 19 On a 4-point Likert scale ranging from ''strongly disagree'' to ''strongly agree,'' the patients rated 6 statements representing their knowledge, skills, and confidence in self-care. Following the PAM developer's guidelines, 20 we summed PAM-6 item responses and transposed the resulting score to a scale ranging from 0 to 100, with higher scores indicating greater activation. In the current sample, internal consistency (Cronbach !) of the PAM-6 was 0.79. Previous analyses of the original 22-item PAM 6 and PAM-13 19 scales found that patient activation develops through 4 stages of (1) not recognizing one"s role in self-care (disengaged, least activated), (2) being aware but lacking necessary skills and confidence (aware), (3) taking action for self-care (taking action), and (4) maintaining selfcare despite challenges (maintaining behaviors, most activated). Using standard PAM-6 cut points provided by the developer, we categorized patients into these 4 stages of activation. Patients with higher levels of activation, as defined by the PAM-6, are more likely to perceive success in achieving health goals, supporting the validity of these categorizations. 21 
Health-Related Quality of Life
We assessed generic HRQOL at 1, 3, and 6 months after hospital discharge with the SF-36v2 Health Survey, 22 which has demonstrable reliability and validity in populations with coronary heart disease (CHD). 23 The physical component summary (PCS) and mental component summary (MCS) scores measure overall physical and mental health, respectively. The PCS and MCS use normbased scoring such that the US general population has a mean of 50 (SD, 10), with higher scores indicating better HRQOL. 24 We selected the 1-month assessment of HRQOL as the baseline measure because this best captures a patient's health in the aftermath of their ACS and avoids endogeneity in measuring changes in HRQOL as related to PAM at 1 month. We used a cutoff of 3.0 points or higher to define clinically meaningful decreases and increases, following published recommendations. 25 We measured disease-specific HRQOL with the 3-item quality of life (QOL) subscale of the Seattle Angina Questionnaire (SAQ), 26 a validated and reliable measure for patients with CHD. 26 This was scored from 0 to 100, with higher scores indicating better HRQOL. Following cutoffs validated in instrument development, we defined decreases and increases of 10.0 points or higher in SAQ QOL as clinically meaningful. 26 
Baseline Study Variables
We controlled for potential confounding by sociodemographic and clinical characteristics including age, sex, race (non-Hispanic white vs other race/ethnicity), and education. Financial strain was measured by asking patients, ''In general, how do your finances usually work out at the end of the month?'' (some money left over, just enough to make ends meet, not enough to make ends meet). 27 Trained staff abstracted data on documented comorbid conditions, health insurance, and referral to cardiac rehabilitation from in-hospital medical records during the patient"s index hospitalization for an ACS. Interviewers asked patients if they had seen an outpatient medical provider for their CHD during the 1-month interview.
Data Analysis
We compared the baseline sociodemographic and clinical characteristics across 1-month patient activation levels through linear tests and Cochran-Armitage tests for trends for continuous and categorical variables, respectively. We compared mean HRQOL scores between 1 month and 3 and 6 months after hospital discharge using paired t tests. Linear tests for trend were used to compare SF-36 PCS, SF-36 MCS, and SAQ QOL scores at each time point across the 4 levels of patient activation.
To test whether patients with lower levels of activation were more likely to experience declines in HRQOL than more-activated patients, we calculated odds ratios (ORs) and 95% confidence intervals (95% CIs) for experiencing a clinically meaningful increase or decrease in HRQOL between 1 month and 3 and 6 months after hospital discharge for an ACS using multinomial logistic regression analyses. In multinomial logistic regression, the outcome takes 1 of 3 or more categories, and models are simultaneously fit using maximum likelihood to estimate ORs for each group compared with a common reference group (ie, no change). 28 For all regression models, maintaining behaviors (the highest activation level) served as the referent group. We included clinical site and sociodemographic factors (age, sex, and race) in multivariate-adjusted models; we included other covariates if their inclusion produced changes in the beta coefficients for the association between activation and HRQOL for at least 1 level of patient activation by 10% or more.
Results
The analytic sample included 1042 (68.1%) of the 1529 Transitions, Risks, and Actions in Coronary Events: Center for Outcomes Research and Education patients who completed the 1-month telephone interview. We excluded patients without 1-month PAM scores (n = 18), did not participate in the 3-and 6-month telephone interviews (n = 422), or were missing HRQOL scores (n = 5) or information on covariates included in multivariable-adjusted models (n = 42). Excluded patients were younger, on average, and were more likely to be non-Hispanic black, have not graduated from high school, report financial strain, and lack health insurance (P G .05 for all comparisons). The distribution of levels of patient activation was statistically similar between included and excluded patients. Included patients had higher mean 1-month MCS (51.0 vs 48.2) and SAQ QOL scores (76.3 vs 71.9) than excluded patients.
Baseline Study Population Characteristics
The mean age of the study population was 61.9 (SD, 11.2) years; 34.3% were women; 87.1% were nonHispanic white; 51.2% had a previous history of CHD. In terms of patient activation, 9.7% were disengaged; 40.3%, aware; 21.1%, taking action; and 28.9%, maintaining behaviors. The level of patient activation was inversely associated with age and with noncompletion of high school (Table 1) . Patient activation was also inversely associated with being nonHispanic white and having a history of previously diagnosed CHD, hyperlipidemia, or cerebrovascular disease. The level of patient activation was not associated with having an outpatient visit after hospital discharge (P = .50).
Physical Health-Related Quality of Life
At months 1, 3, and 6 after patients' hospital discharge, generic physical HRQOL was significantly higher among patients with higher levels of patient activation (Table 2) . On average, PCS scores increased by 1.8 points between 1 and 3 months but remained statistically unchanged, on average, between 3 and 6 months. A similar pattern was observed among patients in each of the 4 different levels of activation. Overall, the proportion of patients experiencing a meaningful improvement in PCS scores between 1 and 3 months (40.5%) and between 1 and 6 months (39.7%) after hospital discharge was nearly double the proportion of patients experiencing a meaningful decrease in PCS scores (23.0% and 25.1%, respectively; Table 3 ). Contrary to our hypothesis, lower patient activation was not associated with clinically meaningful changes in generic physical HRQOL (Table 3) .
Mental Health-Related Quality of Life
On average, patients" MCS scores were also significantly higher among patients with higher activation at 1, 3, and 6 months after hospital discharge (Table 2 ). In the overall study sample, the average MCS score increased by 1.5 points between 1 and 3 months after hospital discharge, with no significant change observed, on average, between 3 and 6 months. Within each level of patient activation, there were small increases in mean MCS scores between 1 and 3 months. However, the patients in the lowest level of activation experienced a nonsignificant 1.1-point decline in the mean MCS score between 3 and 6 months.
A greater proportion of patients experienced a clinically meaningful increase in MCS scores between 1 and 3 months (36.8%), and 1 and 6 months (41.7%), than experienced a clinically meaningful decline (24.1% and 24.7%, respectively) ( Table 4 ). As hypothesized, the patients with the lowest level of activation had 1.95 times (95% CI, 1.05Y3.62) the odds of experiencing a clinically meaningful decrease in general mental HRQOL than the most activated patients between 1 and 6 months, after adjusting for confounding.
Disease-Specific Quality of Life
Disease-specific QOL scores were, on average, significantly greater across patients with higher levels of patient activation at 1, 3, and 6 months after hospital discharge ( Table 2 ). The average SAQ QOL scores for patients in the entire sample increased by 4.3 points between 1 and 3 months after hospital discharge and nonsignificantly increased by 0.6 points between and 3 and 6 months. Mean SAQ QOL scores increased significantly (P G .05) or nonsignificantly for patients within each level of patient activation between 1 and 3 months after hospital discharge. Between 3 and 6 months, the patients in the lowest and highest levels of activation experienced nonsignificant decreases (j1.9 and j1.0 points, respectively) in mean SAQ QOL scores (Table 2) .
Higher proportions of patients in the entire sample reported a clinically meaningful increase in SAQ QOL scores between 1 and 3 months (24.4%), and between 1 and 6 months (26.9%), than reported a meaningful decline (12.8% and 13.5%, respectively) ( Table 5) . After multivariable adjustment, the patients at the lowest level of activation had 2.69 times (95% CI, 1.36Y5.31) and 2.18 times (95% CI, 1.17Y4.05) the odds of the most activated patients of experiencing a clinically meaningful decline in SAQ QOL scores between 1 and 3 months and 1 and 6 months after hospital discharge, respectively; these findings support our hypotheses.
Discussion
We found that hospital survivors of an ACS with the lowest level of patient activation were more likely to experience clinically meaningful declines in generic mental Ref.
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and disease-specific HRQOL compared with the most highly activated patients in the 6 months after hospital discharge. Patients with low activation were older, less educated, and more likely to have previously diagnosed coronary or cerebrovascular disease compared with more-activated patients. The patients with lower activation also had lower generic and disease-specific HRQOL at 1, 3, and 6 months after hospitalization. Approximately half of patients in this study were in the lowest or second lowest level of patient activation at 1 month after hospital discharge for an ACS. Qualitative research suggests that although hospitalization for an ACS may motivate better self-care 29 and perhaps lead to better activation others can find the experience emotionally overwhelming, 30 and this could lead to declines in activation. Our findings of a high prevalence of low patient activation are consistent with studies of other inpatient and outpatient populations with chronic diseases. For example, a national survey in 2004 of 4108 Kaiser Permanente enrollees with chronic diseases, including one third with coronary artery disease, found similar distributions of patient activation. 11 Other studies have found that between 10% and 20% of patients with chronic conditions would be in the lowest level of activation. 10, 31, 32 Our results are notable given the importance of patient self-care in the outpatient setting, particularly after a diagnosis of CHD. 33, 34 Multiple studies have reported that patients from general and chronic disease populations with lower levels of activation tend to have suboptimal self-care behaviors including dieting, exercise, and adherence to prescribed medications. 6, 7, 11 However, patient activation may be modifiable in populations with chronic diseases through interventions such as group workshops, 9 individual coaching, 35, 36 and Internet modules. 37 A trial of 479 patients with at least 1 chronic disease suggested that improvements in patient activation may lead to better self-care behaviors such as improved dietary practices. 9 Further exploration of the long-term consequences of low patient activation after hospital discharge for an ACS is warranted, particularly with regard to the potential benefits of intervening in patients with low levels of activation, and the high prevalence of low levels of patient activation observed in this study. The least activated patients may be the most responsive to interventions for improving activation, 13 and such improvements in activation may be associated with the need for less health care services. 38 We found that patients with lower levels of activation at a month after hospitalization had lower generic and disease-specific HRQOL on average than more-activated patients. Other cross-sectional studies suggest that HRQOL tends to be higher among patients with higher levels of patient activation. 11, 12 In the Kaiser Permanente study of enrollees with a range of chronic diseases, patients in the 3 highest levels of activation had mean SF-8 PCS and MCS scores that were 0.2 to 0.3 points higher than the least-activated patients. 11 Another study of 278 adults (mean age, 53 years) recruited from 2 Israeli primary care clinics found small positive correlations between PAM-13 scores and SF-12 PCS and MCS scores. 12 These previous studies and ours do not shed light on whether lower patient activation may lead to a worse initial HRQOL if suboptimal HRQOL was driving patients to feel less activated or if a third factor negatively affects both patient activation and HRQOL in the aftermath of a hospitalization for an ACS. Future research is needed to better understand the association between patient activation and HRQOL.
The least-activated patients were more likely to experience clinically meaningful declines in generic mental and disease-specific QOL than the mostactivated patients. Survivors of an ACS with better adherence to clinical recommendations are likely to be healthier than their nonadherent peers. 3, 4 The patients with lower activation may be at greater risk for declines in disease-specific HRQOL because of worse self-care; studies in chronic disease populations have identified a strong association between lesser degrees of patient activation and engagement in self-care behaviors. 6, 11 Conceivably, the weaker associations between levels of patient activation with changes in generic physical HRQOL (compared with the stronger associations found for generic mental and for disease-specific HRQOL) may be due to the PCS capturing the effect of other health issues in addition to the ACS.
The association between low patient activation and subsequent declines in generic mental HRQOL could result from a relationship between low patient activation and a negative emotional state. A national survey of 843 adults aged 25 to 75 years found that those with low activation levels tended to feel overwhelmed and worried about managing their health than those with higher activation. 39 After finding that patients with the least activation were less likely to have specific health goals, the authors postulated that the negative effect of the least-activated patients may inhibit their ability to manage their own health. The patients with low activation may, therefore, have psychological barriers to addressing stressors after hospitalization for an ACS. This could explain why patients with lower activation are at higher risk for declines in emotional health over time, whereas those with higher activation could have more capacity to engage in self-care behaviors that also maintain their emotional health. Further research is needed to elucidate the complex, but potentially modifiable, relationships between stressors, mental health, and patient activation among adults after hospitalization for an ACS.
Study Strengths and Limitations
To the best of our knowledge, this is the first prospective study to examine the relationship between patient activation and changes in HRQOL after hospitalization for an ACS. The strengths of this study include a large, contemporary sample of survivors of an ACS and longitudinal assessments of HRQOL using well-validated measures. 23, 26 Limitations include the potential for selection bias due to loss to follow-up, which may have biased findings toward the null because excluded patients were more likely to have markers of socioeconomic deprivation, a potential risk factor for poor outcomes after an ACS. 40 Although the PAM-13 has been validated 19 and used extensively, 7 there are more limited data on the PAM-6, particularly for patients with an ACS. Unmeasured confounders, such as completion of a cardiac rehabilitation program, may have also introduced bias.
Conclusion
Hospital survivors of an ACS at the lowest level of patient activation had lower HRQOL in the months after hospital discharge and were more likely to experience clinically meaningful declines in mental and diseasespecific HRQOL over 6 months, suggesting that patients with low activation may be at particularly high risk of unfavorable outcomes after hospital discharge for an ACS. Further studies are needed to elucidate ways to enhance patient activation and improve their longterm prognosis, including completion of cardiac rehabilitation programs, adherence to effective lifestyle changes, and adherence to medication regimens.
What's New and Important
h This is one of the first studies to examine the relationship between patient activation and changes in HRQOL in the 6 months following hospitalization for an ACS. h The patients in lower levels of activation had lower physical, mental, and disease-specific HRQOL at 1, 3, and 6 months after hospital discharge. h The patients in the lowest level of activation were more likely to experience clinically meaningful declines in mental and disease-specific HRQOL between 1 and 6 months after hospital discharge.
